U.S. flag

An official website of the United States government

NM_000307.5(POU3F4):c.647G>A (p.Gly216Glu) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 13, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000480190.1

Allele description [Variation Report for NM_000307.5(POU3F4):c.647G>A (p.Gly216Glu)]

NM_000307.5(POU3F4):c.647G>A (p.Gly216Glu)

Gene:
POU3F4:POU class 3 homeobox 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq21.1
Genomic location:
Preferred name:
NM_000307.5(POU3F4):c.647G>A (p.Gly216Glu)
HGVS:
  • NC_000023.11:g.83508971G>A
  • NG_009936.2:g.5711G>A
  • NM_000307.5:c.647G>AMANE SELECT
  • NP_000298.3:p.Gly216Glu
  • NC_000023.10:g.82763979G>A
  • NM_000307.4:c.647G>A
Protein change:
G216E
Links:
dbSNP: rs866754647
NCBI 1000 Genomes Browser:
rs866754647
Molecular consequence:
  • NM_000307.5:c.647G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000571979GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Oct 13, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000571979.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The G216E variant in the POU3F4 gene has been reported previously in multiple individuals with X-linked hearing loss in a Chinese family (Li et al., 2010). The G216E variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G216E variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position in the POU-specific domain which is important for protein-DNA interaction and is conserved across species (Li et al., 2010). In silico analysis predicts this variant is probably damaging to the protein structure/function. The G216E variant is a strong candidate for a pathogenic variant, which is likely consistent with the hearing loss reported in this individual and his brother. However, the possibility it may be a rare benign variant cannot be excluded.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022